3 completed, 1 recruiting, 1 terminated, 1 unknown. 5 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 1 | 4 | Completed 1, Recruiting 1, Terminated 1, Unknown 1 |
Follow Squamous Cell Carcinoma of the Cervix: new trials by email Literature Review of Squamous Cell Carcinoma of the Cervix trials Research Report on Squamous Cell Carcinoma of the Cervix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of IDP-001 in Advanced or Metastatic Solid Tumors IDP-001 - Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 / Phase 2 | Recruiting | InduPro, Inc. | 132 | 2026-07-08 | 2026-09-03 |
| SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas SL-279252 - Squamous Cell Carcinoma of the Head and Neck, Melanoma | Phase 1 | Completed | Shattuck Labs, Inc. | 49 | 2019-03-26 | 2025-04-02 |
| Avelumab With Valproic Acid in Virus-associated Cancer Valproic Acid, Avelumab - Cancer That is Associated With a Chronic Viral Infection, p16 Positive SCCHN | Phase 2 | Completed | AHS Cancer Control Alberta | 39 | 2018-02-07 | 2026-11-04 |
| PEN-866 in Patients With Advanced Solid Malignancies PEN-866 Sodium, fluorouracil, Folinic acid - Carcinoma, Endometrial Adenocarcinoma | Phase 1 / Phase 2 | Unknown | Tarveda Therapeutics | 340 | 2017-08-29 | 2022-02-17 |
| A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer OPB-111001 - Prostate Cancer, Salivary Gland Cancer | Phase 1 / Phase 2 | Terminated | Otsuka Novel Products GmbH | 79 | 2014-01-01 | 2015-10-20 |
| Concurrent Treatment of Squamous Cell Carcinoma or Adenocarcinoma of the Cervix With CIGB-300 for Local Application CIGB300 - Squamous Cell Carcinoma of the Cervix, Adenocarcinoma of the Cervix | Phase 2 | Completed | Laboratorio Elea Phoenix S.A. | 18 | 2011-05-01 | 2016-08-02 |
Anus Neoplasms (3) · Carcinoma, Squamous Cell (2) · Squamous Cell Carcinoma of Head and Neck (2) · Breast Neoplasms (1) · Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Carcinoma, Transitional Cell (1) · Endometrial Neoplasms (1) · Esophageal Squamous Cell Carcinoma (1) · Hodgkin Disease (1) · Lymphoma, Large B-Cell, Diffuse (1) · Melanoma (1) · Neoplasm Metastasis (1) · Neoplasms (1)
Neoplasms by Site (4) · Anus Diseases (3) · Colorectal Neoplasms (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Head and Neck Neoplasms (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Rectal Diseases (3) · Rectal Neoplasms (3)
CIGB-300 (1) · Fluorouracil (1) · Leucovorin (1) · Valproic Acid (1) · avelumab (1) · niraparib (1)
AHS Cancer Control Alberta (1) · InduPro, Inc. (1) · Laboratorio Elea Phoenix S.A. (1) · Otsuka Novel Products GmbH (1) · Shattuck Labs, Inc. (1) · Tarveda Therapeutics (1)
United States (3) · Canada (2) · Argentina (1) · Belgium (1) · Spain (1) · United Kingdom (1)
Anish Thomas, MD (1) · Johann De Bono, Prof. Dr. (1) · John Walker, MD PhD FRCPC (1) · Sarah Blagden, Dr. (1)